The POT1 p.P35L variant was detected in all of the affected individuals with cancers, including those with NSCLC, sarcoma, thyroid cancers, as well as the individual with childhood-onset cardiac angiosarcoma (III8) (Table 3). Here, POT1 is linked to sarcoma.